• Takeda Divests Techpool to Joint-Venture Partners in China biospectrumasia
    May 22, 2018
    Techpool’s portfolio of innovative medicines include: Roan (Ulinastatin for Injection), a treatment for acute and chronic pancreatitis, Kallikrein for mid-moderate acute thrombotic cerebral infarction, and Kailikang
PharmaSources Customer Service